Order Article Reprints

Jastrzębska-Więsek M, Kotańska M, Grzeszczak A, Jaromin A, Walczak M, Partyka A, Gdula-Argasińska J, Smolik M, Zagórska A. The Antidepressant-like Activity, Effects on Recognition Memory Deficits, Bioavailability, and Safety after Chronic Administration of New Dual-Acting Small Compounds Targeting Neuropsychiatric Symptoms in Dementia. International Journal of Molecular Sciences. 2022; 23(19):11452. https://doi.org/10.3390/ijms231911452

Jastrzębska-Więsek, Magdalena, Magdalena Kotańska, Aleksandra Grzeszczak, Anna Jaromin, Maria Walczak, Anna Partyka, Joanna Gdula-Argasińska, Magdalena Smolik, and Agnieszka Zagórska. 2022. "The Antidepressant-like Activity, Effects on Recognition Memory Deficits, Bioavailability, and Safety after Chronic Administration of New Dual-Acting Small Compounds Targeting Neuropsychiatric Symptoms in Dementia" International Journal of Molecular Sciences 23, no. 19: 11452. https://doi.org/10.3390/ijms231911452

Jastrzębska-Więsek, M., Kotańska, M., Grzeszczak, A., Jaromin, A., Walczak, M., Partyka, A., Gdula-Argasińska, J., Smolik, M., & Zagórska, A. (2022). The Antidepressant-like Activity, Effects on Recognition Memory Deficits, Bioavailability, and Safety after Chronic Administration of New Dual-Acting Small Compounds Targeting Neuropsychiatric Symptoms in Dementia. International Journal of Molecular Sciences, 23(19), 11452. https://doi.org/10.3390/ijms231911452